Coagulation

Hematology

10 drugs in development·9 companies·1 clinical trial

Drug Pipeline by Phase

Approved(4)

Drug	Company
andexxa	PORTOLA PHARMACEUTICALS INC (PTLA)
heparin	PFIZER INC (PFE)
renuvion apr	Apyx Medical Corporation (APYX)
renuvion micro	Apyx Medical Corporation (APYX)

Phase 3(2)

Drug	Company
tak-330	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
tak-330	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)

Phase 2(2)

Drug	Company
CTX611	CRISPR Therapeutics AG (CRSP)
frunexian	Cadrenal Therapeutics, Inc. (CVKD)

Unknown(2)

Drug	Company
Diagnostic Reagents Division OEM products (unnamed)	BIO-TECHNE Corp (TECH)
i-STAT® and i-STAT® Alinity®	ABBOTT LABORATORIES (ABT)

BioSniper tracks 10 drugs in development for Coagulation across 9 companies.

There are 1 clinical trial targeting Coagulation tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.